Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine... (CPP-109 isintended for the treatment of ...)

HOME >> MEDICINE >> TECHNOLOGY

Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction

Date:6/30/2008

CPP-109 is intended for the treatment of a serious or life-threatening condition for which there is no effective treatment and which demonstrates the potential to address unmet medical needs. For more information about the Company, go to http://www.catalystpharma.com.

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. A number of factors, including our ability to successfully complete the clinical trials required for us to file a new drug application for CPP-109, our ability to complete such trials on a timely basis within the budgets we establish for such trials, our ability to protect our intellectual property and those other factors described in the Company's Annual Report on Form 10-K for 2007 and the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 that the Company has filed with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect the Company. Copies of the Company's filings with the SEC are available from the SEC, may be found on the Company's website or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information contained herein, which speaks only as of this date.

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
2. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
3. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)

Post Your Comments:

(Date:12/15/2009)... LAKE ZURICH, Ill., Dec. 15 Fenwal ... improving blood collection, separation, safety and availability, announced ... has granted Fenwal approval to market InterSol ® ... InterSol ® solution is a specialized product ... donated platelets, a vital blood component used to ...

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... Instrument Manufacturing Industry in the U.S. ... Edition] ,, http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ... of Surgical and Medical Instrument Manufacturing ...

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... - Drug Pipeline Analysis and Market ... http://www.reportlinker.com/p0167308/Systemic-Lupus-Erythematosus---Drug-Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, Systemic Lupus ... Market Forecasts to 2015 ,, ...

[0] Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets [0] Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition][0] Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015

... Inc. today,announced that a Phase 2b dose-ranging study ... company,s lead compound, valomaciclovir,(EPB-348) in patients with acute ... following an interim analysis., Fred Volinsky, MD, ... of this clinical trial and look forward to ...

... Sept. 9 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin Board: CVBT) ... patient enrollment for its Phase II clinical,trial for the ... CVBT anticipates announcing additional sites as they open for,enrollment. ... Phase II heart trial, please visit http://www.cvbt.com ., ...

Other Medicine Technology:Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN) 2 CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial 2

Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial

(Date:12/15/2009)... Watchdog Calls For Preserving State Authority, Ban on ... ,, WASHINGTON, Dec. 15 Consumer Watchdog ... for those over 55 and the public option ... the group said that the Senate must still ... bill to prevent ceding the entire health care ...

(Date:12/15/2009)... taxes in the healthcare bill ,, WASHINGTON, Dec. ... under the "Naughty" column on Americans for Tax Reform,s ... a brazen lie on the floor of the United States ... taxes. ,, Speaking on the U.S. Senate floor on ... I have also heard it argued that health care ...

(Date:12/15/2009)... reproductive age were evaluated, Italian study found , , TUESDAY, ... born with cystic fibrosis decreases when screening for potential ... new study finds. , CF neonatal screening has been ... years. Since the 1990s, the area has seen a ... with CF. , Two different CF carrier detection methods ...

(Date:12/15/2009)... and the CDC have released some sobering statistics concerning the parallel ... desks offer employers an effective means of combating this trend afflicting ... ... 2009 -- Rates of diabetes are climbing across America due in ... this rise the American Diabetes Association has stated that the rate ...

(Date:12/15/2009)... Systems, Inc., a leading provider of advanced inventory ... increase profits by optimizing their inventory and related ... Shoppe has been utilizing the 4R solution since ... solutions have helped us drive significant improvements in ... two years," said Tony Truesdale, President & Chief ...

Breaking Medicine News(10 mins):Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2 Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3 Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4 Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5 Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2 Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3 Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2 Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2 Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4

[0] The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System [0] ATR: Baucus Earns Place on 2009 "Naughty" List [0] Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis [2] TrekDesk: A Potentially Positive Impact on Diabetes & Obesity [1] 4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance

... outbreak in the Sydney CBD is linked to the Royal ... suspect//. However, they could not confirm the link. ... bacteria belonging to the Legionella family, Legionella pneumophilia, have been ... in the Circular Quay area on New Year's Eve. ...

... discovered a unique way to switch off a gene involved ... a chemical found in cell nuclei, whose role until now ... and its role in offsetting the development of tumor cells. ... the synthesis of proteins, the building blocks of our bodies. ...

... study of fish by researchers from the February issue ... that male fish are more likely// to eat their ... of spawning. ,"The most drastic decision a ... writes Suzanne Gray (Ph.D. candidate at Simon Fraser University), ...

... the March 1, 2007 issue of CANCER, a peer-reviewed journal ... highly effective breast cancer drug may negatively affect treatment efficacy. ... third of women have ceased tamoxifen treatment. ... treated for breast cancer stop tamoxifen within one year, a ...

... Head Start programs have discovered that those from families// ... higher risk for being overweight. ,The study ... that Mexican children “were almost twice as likely to ... ethnic groups, including non-Mexican Hispanic children.” ...

... said to have a beneficial effect on the health of men. ... are the following // ,Vegetables like tomatoes, carrot, garlic and ... food like oysters, shrimps and deep sea fish has the similar ... proteins and nutrients and also help in secretion of gastric acid. ...

Other Medicine News:Health News:Role of RNA in Checking the Development of Tumors 2 Health News:Tamoxifen Discontinuation Rates Surprisingly High 2 Health News:Head Start Kids in ESL Families More Prone to Obesity 2

Legionnaires' Outbreak Linked to RAC Role of RNA in Checking the Development of Tumors Male Fish Cannibalize Its Own Offspring Than Female Tamoxifen Discontinuation Rates Surprisingly High Head Start Kids in ESL Families More Prone to Obesity Diet Holds the Key for Men's Health

An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...

An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...

... NEW Research Grade Microscope Camera ... a superior imaging technology that delivers ... accuracy at an affordable price. ... high resolution 3.3 mega-pixel digital microscope ...

The ImagingPlanet 70 mm surgical microscope video adapter: Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgica...

Medicine Products:

ImmuLisa™ anti-2-GP1 IgG Kit ImmuLisa™ IgG-ACA anti-Cardiolipin Antibody (ACA) Kit 3.3MPX Digital Microscope Camera Leica L-70 Style Surgical Microscope Video Adapter from ImagingPlanet

Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine...(CPP-109 isintended for the treatment of ...),Health